Myristoleic acid
|
Basic information |
| Metabolite name | Myristoleic acid |
 | HMDB0002000 |
 |
C08322 |
 |
5281119 |
| Synonyms | NA |
| No. of studies | 4 |
|
Basic information |
| Metabolite name | Myristoleic acid |
| HMDB0002000 |
|
C08322 |
|
5281119 |
| Synonyms | NA |
| No. of studies | 4 |
|
Relationship between Myristoleic acid and depression (count: 4) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1024 | Type1 | CUMS group vs. control group | CA3 region of hippocampus | ICR mouse | Down |
| Study M1024 | Type1 | CUMS group vs. control group | CA1 region of hippocampus | ICR mouse | Down |
| Study M1024 | Type1 | CUMS group vs. control group | DG region of hippocampus | ICR mouse | Down |
| Study M1024 | Type2 | CUMS + hydroxytyrosol group vs. CUMS group | DG region of hippocampus | ICR mouse | Up |
| Study M1024 | Type2 | CUMS + hydroxytyrosol group vs. CUMS group | CA1 region of hippocampus | ICR mouse | Up |
| Study M1024 | Type2 | CUMS + hydroxytyrosol group vs. CUMS group | CA3 region of hippocampus | ICR mouse | Up |
| Study M1063 | Type1 | MDD group vs. control group | Plasma | Human | Up |
| Study M669 | Type1 | corticosterone group vs. control group | Liver | C57BL/6J mouse | Up |
| Study M907 | Type1 | MDD group vs. control group | Plasma | Human | Up |